OP40 PRA023 Demonstrated Efficacy and Favorable Safety as Induction Therapy for Moderately to Severely Active UC: Phase 2 ARTEMIS-UC Study Results
暂无分享,去创建一个
L. Peyrin-Biroulet | S. Danese | J. Kierkuś | S. Targan | B. Feagan | R. Kempiński | J. Leszczyszyn | T. Ritter | S. Vermeire | B. Sands | A. Wiechowska‐Kozłowska | A. Luo | D. Nguyen | D. Rubin | C. Ma | O. Laurent | J. Lu